Role of energy metabolism in the preconditioned heart - A possible contribution of mitochondria

Cardiovascular Research

Volumn 43, Issue 1, 1999, Pages 32-43

  Takeo, Satoshi ^a   Nasa, Yoshihisa ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Acidosis; Adenosine; Glycolytic flux; Ischemia; K(ATP) channel; Mitochondria; Mitochondrial ATPase; Preconditioning

Indexed keywords

BRADYKININ; FREE RADICAL; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; POTASSIUM CHANNEL; PROTEIN; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

ACIDOSIS; ENERGY METABOLISM; ENZYME ACTIVITY; GLYCOLYSIS; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; HUMAN; HUMAN TISSUE; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; REVIEW;

EID: 0032998058     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00079-6     Document Type: Review

References (143)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
2. Dekker L.R.C. Toward the heart of ischemic preconditioning. Cardiovasc Res. 37:1998;14-20.
3. Yellon D.M., Baxter G.F., Garcia-Dorado D., Heusch G., Sumeray M.S. Ischaemic preconditioning: present position and future directions. Cardiovasc Res. 37:1998;21-33.
4. 1 adenosine receptors in rabbit heart. Circulation. 84:1991;350-356.
5. Downey J.M., Liu G.S., Thornton J.D. Adenosine and the anti-infarct effects of preconditioning. Cardiovasc Res. 27:1993;3-8.
6. ATP channels, and ischemic preconditioning in dogs. Am J Physiol. 264:1993;H1327-H1336.
7. Kitakaze M., Hori M., Takashima S., et al. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs: implications for myocardial salvage. Circulation. 87:1993;208-215.
8. Wall T.M., Sheehy R., Hartman J.C. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther. 270:1994;681-689.
9. Goto M., Liu Y., Yang X.-M., et al. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 77:1995;611-621.
10. Liu Y., Tsuchida A., Cohen M.V., Downey J.M. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol. 27:1995;883-892.
11. 1-adrenergic mechanism. Circ Res. 73:1993;656-670.
12. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res. 75:1994;576-585.
13. Schultz J.E.J., Rose E., Yao Z., Gross G.J. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol. 268:1995;H2157-H2161.
14. Hide E.J., Piper J., Thiemermann C. Endothelin-1-induced reduction myocardial infarct size by activation of ATP-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion. Br J Pharmacol. 116:1995;2597-2602.
15. Wang P., Gallagher K.P., Downey J.M., Cohen M.V. Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart. J Mol Cell Cardiol. 28:1996;579-588.
16. Liu Y., Ytrehus K., Downey J.M. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol. 26:1994;661-668.
17. Speechly-Dick M.E., Mocanu M.M., Yellon D.M. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res. 75:1994;586-590.
18. Ytrehus K., Liu Y., Downey J.M. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 266:1994;H1145-H1152.
19. Li Y., Kloner R.A. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol. 268:1995;H426-H431.
20. 1-Adrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation. 91:1995;2226-2234.
21. Mitchell M.B., Meng X., Ao L., et al. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res. 76:1995;73-81.
22. Przyklenk K., Sussman M.A., Simkhovich B.Z., Kloner R.A. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation. 92:1995;1546-1557.
23. Vahlhaus C., Schulz R., Post H., Onallah R., Heusch G. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res. 79:1996;407-414.
24. Baines C.P., Wang L., Cohen M.V., Downey J.M. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J Mol Cell Cardiol. 30:1998;383-392.
25. Weinbrenner C., Liu G.S., Cohen M.V., Downey J.M. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol. 29:1997;2383-2391.
26. Armstrong S., Delacey M., Ganote C. p38 MAPK phosphorylation in rabbit cardiomyocytes: protein phosphatase inhibition and ischemic preconditioning. J Mol Cell Cardiol. 30:1998;A149.
27. Chen W., Murphy E., Steenbergen C. Role of p38 MAP kinase in ischemic preconditioning in rat heart. J Mol Cell Cardiol. 30:1998;A148.
28. Ovize M., Przyklenk K., Hale S.L., Kloner R.A. Preconditioning does not attenuate myocardial stunning. Circulation. 85:1992;2247-2254.
29. Jenkins D.P., Pugsley W.B., Yellon D.M. Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning. J Mol Cell Cardiol. 27:1995;1623-1632.
30. Ovize M., Aupetit J.F., Rioufol G., et al. Preconditioning reduces infarct size but accelerates time to ventricular fibrillation in ischemic pig heart. Am J Physiol. 269:1995;H72-H79.
31. Murry C.E., Richard V.J., Reimer K.A., Jennings R.B. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 66:1990;913-931.
32. Jennings R.B., Murry C.E., Reimer K.A. Myocardial effects of brief periods of ischemia followed by reperfusion. Lelleremann J.J., Braunwald E. Silent Myocardial Ischaemia: A Critical Appraisal. Advances in Cardiology. 37:1990;7-31 Karger, Basel.
33. Asimakis G.K., Inners-McBride K., Medellin G., Conti V.R. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physiol. 263:1992;H887-H894.
34. Wolfe C.L., Sievers R.E., Visseren F.L.J., Donnelly T.J. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation. 87:1993;881-892.
35. De Albuquerque C.P., Gerstenblith G., Weiss R.G. Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts. Circ Res. 74:1994;139-150.
36. Janier M.F., Vanoverschelde J.C., Bergmann S.R. Ischemic preconditioning stimulates anaerobic glycolysis in the isolated rabbit heart. Am J Physiol. 267:1994;H1353-H1360.
37. Yabe K., Nasa Y., Sato M., Iijima R., Takeo S. Preconditioning preserves mitochondrial function and glycolytic flux during an early period of reperfusion in perfused rat hearts. Cardiovasc Res. 33:1997;677-685.
38. Miyamae M., Fujiwara H., Kida M., et al. Preconditioning improves energy metabolism during reperfusion but does not attenuate myocardial stunning in porcine hearts. Circulation. 88:1993;223-234.
39. Kobara M., Tatsumi T., Matoba S., et al. Effect of ischemic preconditioning on mitochondrial oxidative phosphorylation and high energy phosphates in rat hearts. J Mol Cell Cardiol. 28:1996;417-428.
40. o-ATPase. Circulation. 91:1995;2810-2818.
41. o-ATPase inhibition. Am J Physiol. 274:1998;H90-H97.
42. + channels: possible mechanism of cardioprotection. Circ Res. 81:1997;1072-1082.
43. Liu Y., Sato T., O'Rourke B., Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation. 97:1998;2463-2469.
44. + channels by protein kinase C. Circ Res. 83:1998;110-114.
45. Tritto I., D'Andreas D., Eramo N., et al. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res. 80:1997;743-748.
46. Vanden Hoek T.L., Becker L.B., Shao Z., Li C., Schumacker P.T. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem. 273:1998;18092-18098.
47. Dennis S.C., Gevers W., Opie L.H. Protons in ischemia: where do they come from; where do they go to? J Mol Cell Cardiol. 23:1991;1077-1086.
48. Solaro R.J., Lee J.A., Kentish J.C., Allen D.G. Effects of acidosis on ventricular muscle from adult and neonatal rats. Circ Res. 63:1988;779-787.
49. Fabiato A., Fabiato F. Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiac and skeletal muscles. J Physiol (Lond). 276:1978;233-255.
50. Orchard C.H. The role of the sarcoplasmic reticulum in the response of ferret and rat heart muscle to acidosis. J Physiol (Lond). 384:1987;431-449.
51. 2+ and tension in isolated ferret ventricular muscle. J Physiol (Lond). 410:1989;297-323.
52. Steenbergen C., Murphy E., Levy L., London R.E. Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res. 60:1987;700-707.
53. Steenbergen C., Fralix T.A., Murphy E. Role of increased cytosolic free calcium concentration in myocardial ischemic injury. Basic Res Cardiol. 88:1993;456-470.
54. Steenbergen C., Perlman M.E., London R.E., Murphy E. Mechanism of preconditioning: ionic alterations. Circ Res. 72:1993;112-125.
55. Schaefer S., Carr L.J., Prussel E., Ramasamy R. Effects of glycogen depletion on ischemic injury in isolated rat hearts: insights into preconditioning. Am J Physiol. 268:1995;H935-H944.
56. Chen W., Wetsel W., Steenbergen C., Murphy E. Effect of ischemic preconditioning and PKC activation on acidification during ischemia in rat heart. J Mol Cell Cardiol. 28:1996;871-880.
57. Kolocassides K.G., Seymour A.M.L., Galinanes M., Hearse D.J. Paradoxical effect of ischemic preconditioning on ischemic contracture? NMR studies of energy metabolism and intracellular pH in the rat heart. J Mol Cell Cardiol. 28:1996;1045-1057.
58. Opie L.H. Hypothesis: glycolytic rates control cell viability in ischaemia. J Appl Cardiol. 3:1988;407-414.
59. Harada K., Franklin A., Johnson R.G., Grossman W., Morgan J.P. Acidemia and hypernatremia enhance postischemic recovery of excitation-contraction coupling. Circ Res. 74:1994;1197-1209.
60. Sanz E., Garcia-Dorado D., Oliveras J., et al. Dissociation between anti-infarct effect and anti-edema effect of ischemic preconditioning. Am J Physiol. 268:1995;H233-H241.
61. Neely J.R., Grotyohann L.W. Role of glycolytic products in damage to ischemic myocardium: dissociation of adenosine triphosphate levels and recovery of function of perfused ischemic hearts. Circ Res. 55:1984;816-824.
62. McNulty P.H., Darling A., Whiting J.M. Glycogen depletion contributes to ischemic preconditioning in the rat heart in vivo. Am J Physiol. 271:1996;H2283-H2289.
63. Asimakis G.K., Inners-McBride K., Conti V.R., Yang C. Transient β adrenergic stimulation can precondition the rat heart against postischaemic contractile dysfunction. Cardiovasc Res. 28:1994;1726-1734.
64. Nasa Y., Yabe K., Takeo S. β-Adrenoceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts. J Cardiovasc Pharmacol. 29:1997;436-443.
65. Asimakis G.K. Myocardial glycogen depletion cannot explain the cardioprotective effects of ischemic preconditioning in the rat heart. J Mol Cell Cardiol. 28:1996;563-570.
66. Rouslin W. Protonic inhibition of the mitochondrial oligomycin-sensitive adenosine 5′-triphosphatase in ischemic and autolyzing cardiac muscle. J Biol Chem. 258:1983;9657-9661.
67. Rouslin W., Erickson J.L., Solaro R.T. Effects of oligomycin and acidosis on rates of ATP depletion in ischemic heart muscle. Am J Physiol. 250:1986;H503-H508.
68. Veksler V., Ventura-Clapier R. Ischaemic metabolic factors: high inorganic phosphate and acidosis modulate mitochondrial creatine kinase functional activity in skinned cardiac fibers. J Mol Cell Cardiol. 26:1994;335-339.
69. 1-adenosine receptors. Am J Physiol. 257:1989;H1952-H1957.
70. Weiss J., Hiltbrand B. Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart. J Clin Invest. 75:1985;436-447.
71. i elevation and ATP depletion. Am J Physiol. 258:1990;H9-H16.
72. Owen P., Dennis S., Opie L.H. Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. Circ Res. 66:1990;344-354.
73. 31P-NMR study of isolated rat hearts. Am J Physiol. 261:1991;H469-H478.
74. Lasley R.D., Anderson G.M., Mentzer R.M. Jr. Ischaemic and hypoxic preconditioning enhance postischemic recovery of function in the rat heart. Cardiovasc Res. 27:1993;565-570.
75. Cave A.C., Horowitz G.L., Apstein C.S. Can ischemic preconditioning protect against hypoxia-induced damage? Studies of contractile function in isolated perfused rat hearts. J Mol Cell Cardiol. 26:1994;1471-1486.
76. + channel. Heart Vessels. 10:1995;294-303.
77. Newsholme E.A. The regulation of phosphofructokinase in muscle. Cardiology. 6:1971/72;22-34.
78. Rovetto M.J., Lamberton W.F., Neely J.R. Mechanisms of glycolytic inhibition is ischemic rat hearts. Circ Res. 37:1975;742-751.
79. Jennings R.B., Murry C.E., Reimer K.A. Energy metabolism in preconditioned and control myocardium: effect of total ischemia. J Mol Cell Cardiol. 23:1991;1449-1458.
80. Kida M., Fujiwara H., Ishida M., et al. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation. 84:1991;2495-2503.
81. Jarmakani J.M., Nakagawa M., Nagatomo T., Langer G.A. Effect of hypoxia on mechanical function in the neonatal mammalian heart. Am J Physiol. 235:1978;H469-H474.
82. Hearse D.J. Oxygen deprivation and early myocardial contractile failure: a reassessment of the possible role of adenosine triphosphate. Am J Cardiol. 44:1979;1115-1121.
83. Volovsek A., Subramanian R., Reboussin D. Effects of duration of ischaemia during preconditioning on mechanical function, enzyme release and energy production in the isolated working rat heart. J Mol Cell Cardiol. 24:1992;1011-1019.
84. Finegan B.A., Lopaschuk G.D., Gandhi M., Clanachan A.S. Ischemic preconditioning inhibits glycolysis and proton production in isolated working rat hearts. Am J Physiol. 269:1995;H1767-H1775.
85. Cave A.C., Hearse D.J. Ischaemic preconditioning and contractile functions: studies with normothermic and hypothermic global ischaemia. J Mol Cell Cardiol. 24:1992;1113-1123.
86. Chen W., Gabel S., Steenbergen C., Murphy E. A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ Res. 77:1995;424-429.
87. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res. 28:1994;1057-1061.
88. LaMonica D.A., Frohloff N., Dobson J.G. Jr. Adenosine inhibition of catecholamine stimulated cardiac membrane adenylate cyclase. Am J Physiol. 248:1985;H737-H744.
89. Richardt G., Waas W., Kranzhofer R., Mayer E., Schomig A. Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. Circ Res. 61:1987;117-123.
90. Vander Heide R.S., Reimer K.A., Jennings R.B. Adenosine slows ischaemic metabolism in canine myocardium in vitro: relationship to ischaemic preconditioning. Cardiovasc Res. 27:1993;669-673.
91. Miura T., Ogawa T., Iwamoto T., Shimamoto K., Iimura O. Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. Circulation. 86:1992;979-985.
92. Li Y., Kloner R.A. The cardioprotective effects of ischemic "preconditioning" are not mediated by adenosine receptors in rat hearts. Circulation. 87:1993;1642-1648.
93. Cave A.C., Collis C.S., Downey J.M., Hearse D.J. Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc Res. 27:1993;663-668.
94. 1 receptors by G proteins in rat ventricular myocytes. Am J Physiol. 259:1990;H820-H826.
95. Murphy E., Fralix T.A., London R.E., Steenbergen C. Effects of adenosine antagonists on hexose uptake and preconditioning in perfused rat heart. Am J Physiol. 265:1993;C1146-C1155.
96. Di Lisa F., Menabo R., Canton M., Petronilli V. The role of mitochondria in the salvage and the injury of the ischemic myocardium. Biochim Biophys Acta. 1366:1998;69-78.
97. Rouslin W., Millard R.W. Mitochondrial inner membrane enzyme defects in porcine myocardial ischemia. Am J Physiol. 240:1981;H308-H313.
98. Young H.H., Shimizu T., Nishioka K., Nakanishi T., Jarmakani J.M. Effect of hypoxia and reoxygenation on mitochondrial function in neonatal myocardium. Am J Physiol. 245:1983;H998-H1006.
99. Henke W., Jung K. Ischemia decreases the content of the adenine nucleotide translocator in mitochondria of rat kidney. Biochim Biophys Acta. 1056:1991;71-75.
100. Hinkle P.C., McCarty R.E. How cells make ATP. Sci Am. 238:1978;104-123.
101. Kagawa Y. Proton motives ATP synthesis. Colowick S.P., Kaplan N.I.O. Energetics. 1984;593-595 Academic Press, New York.
102. Jennings R.B., Reimer K.A., Steenbergen C. Effect of inhibition of the mitochondrial ATPase on net myocardial ATP in total ischemia. J Mol Cell Cardiol. 23:1991;1383-1395.
103. Vander Heide R.S., Hill M.L., Steenbergen C., Reimer K.A., Jennings R.B. Effect of reversible ischemia on mitochondrial ATPase activity in canine myocardium. Circulation. 84:(Suppl II):1991;II-192.
104. Di Lisa F., Blank P.S., Colonna R., et al. Mitochondrial membrane potential in single living adult rat cardiac myocytes exposed to anoxia or metabolic inhibition. J Physiol (Lond). 486:1995;1-13.
105. Vander Heide R.S., Hill M.L., Reimer K.A., Jennings R.B. Effect of reversible ischemia on the activity of the mitochondrial ATPase: relationship to ischemic preconditioning. J Mol Cell Cardiol. 28:1996;103-112.
106. Pullman M.E., Monroy G.C. A naturally occurring inhibitor of mitochondrial adenosine triphosphatase. J Biol Chem. 238:1963;3762-3769.
107. Frangione B., Rosenwasser E., Penefsky H.S., Pullman M.E. Amino acid sequence of the protein inhibitor of mitochondrial adenosine triphosphatase. Proc Natl Acad Sci USA. 78:1981;7403-7407.
108. Rouslin W. Regulation of the mitochondrial ATPase in situ in cardiac muscle: role of the inhibitor subunit. J Bioenerg Biomembr. 23:1991;873-888.
109. 1 content, and proton conductivity of ESMP from control and ischemic slow and fast heart-rate hearts. J Bioenerg Biomembr. 27:1995;459-466.
110. 1 function in situ in uncoupler-challenged ischemic rabbit, rat, and pigeon hearts. J Biol Chem. 271:1996;23638-23641.
111. Rouslin W. The mitochondrial adenosine 5′-triphosphatase in slow and fast heart rate hearts. Am J Physiol. 252:1987;H622-627.
112. + channels in cardiac muscle. Nature. 305:1983;147-148.
113. Cook N.S. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci. 9:1988;21-28.
114. Grover G.J., McCullough J.R., Henry D.E., Conder M.L., Sleph P.G. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther. 251:1989;98-110.
115. Mitani A., Kinoshita K., Fukamachi K., et al. Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion in isolated perfused rat hearts. Am J Physiol. 261:1991;H1864-H1871.
116. + channels protect the myocardium against ischemia/reperfusion damage. Circ Res. 69:1991;571-581.
117. Auchampach J.A., Grover G.J., Gross G.J. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res. 26:1992;1054-1062.
118. Gross G.J., Auchampach J.A. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 70:1992;223-233.
119. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation. 89:1994;1769-1775.
120. ATP channel opener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol. 26:1995;145-152.
121. Liu Y., Gao W.D., O'Rourke B., Marban E. Cell-type specificity of preconditioning in an in vitro model. Basic Res Cardiol. 91:1996;450-457.
122. ATP channel. Am J Physiol. 271:1996;H1769-H1777.
123. Thornton J.D., Thornton C.S., Sterling D.L., Downey J.M. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ Res. 72:1993;44-49.
124. Liu Y., Downey J.M. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol. 263:1992;H1107-H1112.
125. Grover G.J., Dzwonczyk S., Sleph P.G., Sargent C.A. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts. J Pharmacol Exp Ther. 265:1993;559-564.
126. ATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol. 75:1997;309-315.
127. + channel in the mitochondrial inner membrane. Nature. 352:1991;244-247.
128. + channel from rat liver and beef heart mitochondria. J Biol Chem. 267:1992;26062-26069.
129. Garlid K.D. Cation transport in mitochondria: the potassium cycle. Biochim Biophys Acta. 1275:1996;123-126.
130. Grover G.J., Newburger J., Sleph P.G., et al. Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides. J Pharmacol Exp Ther. 257:1991;156-162.
131. + channels involves high-energy phosphate preservation. Am J Physiol. 265:1993;H1809-H1818.
132. Chambers D.E., Parks D.A., Patterson G., et al. Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol. 17:1985;145-152.
133. Fantone J.C., Ward P.A. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol. 107:1982;397-418.
134. Ambrosio G., Zweier J.L., Duilio C., et al. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem. 268:1993;18532-18541.
135. Das D.K., Engelman R.M., Kimura Y. Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischaemia. Cardiovasc Res. 27:1993;578-584.
136. 2 generation and prevents respiratory impairment in the mitochondria of post-ischemic reperfused heart of rat. Life Sci. 60:1997;2207-2219.
137. Zhou X., Zhai X., Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation. 93:1996;1177-1184.
138. Murry C.E., Richard V.J., Jennings R.B., Reimer K.A. Preconditioning with ischaemia: is the protective effect mediated by free radical induced myocardial stunning? Circulation. 78:(Suppl II):1988;77.
139. Ambrosio G., Tritto I., Chiariello M. The role of oxygen free radicals in preconditioning. J Mol Cell Cardiol. 27:1995;1035-1039.
140. 2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci USA. 86:1989;6758-6762.
141. Baines C.P., Goto M., Downey J.M. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol. 29:1997;207-216.
142. Tanaka M., Fujiwara H., Yamasaki K., Sasayama S. Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischaemic preconditioning in the rabbit. Cardiovasc Res. 28:1994;980-986.
143. Osada M., Takeda S., Sato T., Komori S., Tamura K. The protective effect of preconditioning on reperfusion-induced arrhythmia is lost by treatment with superoxide dismutase. Jpn Circ J. 58:1994;259-263.